S. Kondo et al., INTERLEUKIN-10 INHIBITS THE ELICITATION PHASE OF ALLERGIC CONTACT HYPERSENSITIVITY, Journal of investigative dermatology, 103(6), 1994, pp. 811-814
Interleukin-10 (IL-10) is known to play a major role in suppressing im
mune and inflammatory responses by inhibiting the production of proinf
lammatory cytokines. Therefore, we hypothesized that IL-10 might be ca
pable of suppressing allergic contact hypersensitivity. BALB/c mice we
re sensitized on the dorsal skin with dinitrofluorobenzene and challen
ged on the ears 6 d later. The effect of IL-10 on the elicitation phas
e of contact sensitization was determined by its intradermal injection
into the pinnae of the mice at doses of 0.1-100 ng. At 24 and 48 h af
ter challenge, ear swelling was suppressed in a dose-dependent manner
by injection of IL-10 at doses of 10-100 ng. Maximal inhibition of ear
swelling (46.9%) was observed after injection of 100 ng of IL-10. IL-
10-injected ear skins showed less inflammatory cell infiltration and d
ecreased edema at the dermis compared with controls. Because IL-10 is
known to inhibit Th1 cytokines such as interferon-gamma, we examined w
hether the suppressive effect of IL-10 on ear swelling was accompanied
by IL-10-induced inhibition of interferon-gamma. We found that IL-10
application suppressed interferon-gamma mRNA upregulation in challenge
d skin. Our results suggest that IL-10 significantly modifies the elic
itation of allergic contact sensitivity reactions.